ProFound Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ProFound Therapeutics, Inc. - overview
Established
2020
Location
Cambridge, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2020, ProFound Therapeutics, Inc. engages in the discovery of a human proteome that uses protein detection technologies to develop potential new medicines. In May 2022, Flagship Pioneering launched ProFound Therapeutics, Inc. with an investment of USD 75 million.
ProFound Therapeutics, Inc. is developing a therapeutic target discovery platform with the goal of improving biotechnology. The firm approach uses modern protein detection technologies to completely identify and validate proteins, revealing the therapeutic potential. Biotech researchers have access to a functionality, and roles in health and illness.
The firm's platform takes a thorough approach to discovering possible targets for therapeutic interventions.
Current Investors
Flagship Pioneering
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.profoundtx.com/
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
ProFound Therapeutics, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | ProFound Therapeutics, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.